Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. SC 13D/A Stake Beneficial Ownership Report
  2. EFFECT Other Notice of Effectiveness
  3. 424B3 Offering Prospectus
  4. UPLOAD Other SEC-generated Letter
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. S-1 Offering Registration Statement
  7. SC 13G Stake Amended Statement of Ownership
  8. D Other Notice of Sales of Unregistered Securities
  9. SC 13G Stake Amended Statement of Ownership
  10. 10-Q Report Quarterly Report
  11. 8-K Event Material agreement · Unregistered share sale
  12. 424B5 Offering Prospectus
  13. SC 13G Stake Amended Statement of Ownership
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Regulation FD disclosure
  16. EFFECT Other Notice of Effectiveness
  17. 424B5 Offering Prospectus
  18. 10-Q Report Quarterly Report
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. S-3/A Offering Registration Statement

Page 22 of 72 · 1,429 filings